Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Overweight Clinical Trials

8 recruiting trials for Overweight. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
8
Total Trials
8
Recruiting Now
4
Phase 3 Trials
6
Sponsors

Recruiting Trials

Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.

RECRUITINGNCT06595251

Community Park-Based Programs for Health Promotion: Fit2Play Prospective Cohort Study

The Fit2Play prospective cohort study examines the effects of a park-based youth physical activity afterschool program on youth participant fitness and mental health outcomes....

Sponsor: Duke UniversityEnrolling: 50001 location
RECRUITINGNCT06497946

Effects of SlimTrack® Platform on Diet Adherence, Anthropometry and Arterial Stiffness in Postmenopausal Women

Introduction:The weight gain expected in the postmenopausal period has deleterious effects on the physical and mental health of the female population. Management of this situation...

Sponsor: Instituto de Cardiologia do Rio Grande do SulEnrolling: 641 location
RECRUITINGPhase 3NCT06972459

A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and at Least One Weight-Related...

The main purpose of this study is to see how orforglipron, compared with placebo, helps reduce body weight in participants with obesity or with overweight and at least one other...

Sponsor: Eli Lilly and CompanyEnrolling: 60020 locations
RECRUITINGPhase 3NCT07232719

A Study of Retatrutide (LY3437943) in Participants With Obesity or Overweight

The purpose of this study is to evaluate the efficacy and safety of retatrutide compared with placebo for body weight reduction. Participation in the study will last about 65...

Sponsor: Eli Lilly and CompanyEnrolling: 25020 locations
RECRUITINGPhase 3NCT06839664

A Study of HS-20094 in Chinese Adults with Overweight or Obesity

The main purpose of this study is to assess the Efficacy and safety of HS-20094 in overweight and obese patients. The study will last up to approximately 52 weeks.

Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd.Enrolling: 6101 location
RECRUITINGPhase 3NCT06672939

A Study of Orforglipron (LY3502970) in Adolescent Participants With Obesity, or Overweight With Related Comorbidities

The main purpose of this study, performed under Master Protocol J4M-MC-PWMP, is to evaluate the efficacy, safety, and pharmacokinetics of orforglipron once daily oral versus...

Sponsor: Eli Lilly and CompanyEnrolling: 12520 locations
RECRUITINGPhase 1NCT07400679

A Study to Learn How the Study Medicine Called PF-08653944 is Taken up Into the Blood in Adults With Overweight or...

This study is being done to learn how the study medicine affects the body and how safe it is for people who take it. The researchers will look at a number of health tests,...

Sponsor: PfizerEnrolling: 541 location
RECRUITINGNCT04496895

The Evaluation of Orange Peel Fermentation on Body Fat Lowering Efficacy in Adults

To assess whether orange peel fermentation has the effect of reducing body fat in adults

Sponsor: TCI Co., Ltd.Enrolling: 1241 location

Frequently Asked Questions

There are currently 8 clinical trials for Overweight, with 8 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.

To join a clinical trial for Overweight, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.

Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 4 Phase 3 trials for Overweight, representing treatments closest to potential FDA approval.

Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.

Sources: ClinicalTrials.gov, FDA
Last updated:

Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice — always talk to your doctor about clinical trial participation.